Abstract |
The polyketide natural product borrelidin displays antibacterial, antifungal, antimalarial, anticancer, insecticidal and herbicidal activities through the selective inhibition of threonyl-tRNA synthetase (ThrRS). How borrelidin simultaneously attenuates bacterial growth and suppresses a variety of infections in plants and animals is not known. Here we show, using X-ray crystal structures and functional analyses, that a single molecule of borrelidin simultaneously occupies four distinct subsites within the catalytic domain of bacterial and human ThrRSs. These include the three substrate-binding sites for amino acid, ATP and tRNA associated with aminoacylation, and a fourth 'orthogonal' subsite created as a consequence of binding. Thus, borrelidin competes with all three aminoacylation substrates, providing a potent and redundant mechanism to inhibit ThrRS during protein synthesis. These results highlight a surprising natural design to achieve the quadrivalent inhibition of translation through a highly conserved family of enzymes.
|
Authors | Pengfei Fang, Xue Yu, Seung Jae Jeong, Adam Mirando, Kaige Chen, Xin Chen, Sunghoon Kim, Christopher S Francklyn, Min Guo |
Journal | Nature communications
(Nat Commun)
Vol. 6
Pg. 6402
(Mar 31 2015)
ISSN: 2041-1723 [Electronic] England |
PMID | 25824639
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Escherichia coli Proteins
- Fatty Alcohols
- borrelidin
- Threonine-tRNA Ligase
|
Topics |
- Amino Acid Sequence
- Binding Sites
- Catalytic Domain
- Crystallography, X-Ray
- Escherichia coli
- Escherichia coli Proteins
(antagonists & inhibitors, metabolism)
- Fatty Alcohols
(metabolism)
- Humans
- Organisms, Genetically Modified
- Threonine-tRNA Ligase
(antagonists & inhibitors, genetics, metabolism)
- Transfer RNA Aminoacylation
- Yeasts
(genetics)
|